Inflamm-aging of the stem cell niche: Breast cancer as a paradigmatic example: Breakdown of the multi-shell cytokine network fuels cancer in aged people

BioEssays

Volumn 34, Issue 1, 2012, Pages 40-49

  Bonafè, Massimiliano ^a,b   Storci, Gianluca ^a,b   Franceschi, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Ageing; Cancer; DNA damage; Inflammation; Stem cell; Stem cell niche

Indexed keywords

CYTOKINE;

AGING; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CHRONIC INFLAMMATION; DNA DAMAGE; EPIGENETICS; FIBROBLAST; GENE MUTATION; HUMAN; INFLAMMATION; MACROPHAGE; MAMMARY GLAND; STEM CELL;

AGED; AGING; BREAST NEOPLASMS; CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; DISEASE PROGRESSION; DNA DAMAGE; FEMALE; FIBROBLASTS; HUMANS; INFLAMMATION; MACROPHAGES; SIGNAL TRANSDUCTION; STEM CELL NICHE; STEM CELLS; STROMAL CELLS;

EID: 83555177230     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201100104     Document Type: Article

References (99)

1. Franceschi C, Bonafè M, Valensin S, Olivieri F, et al. 2000. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908: 244- 54.
2. Franceschi C, Bonafè M. 2003. Centenarians as a model for healthy aging. Biochem Soc Trans 31: 457- 61.
3. Franceschi C, Capri M, Monti D, Giunta S, et al. 2007. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128: 92- 105.
4. Balkwill F, Mantovani A. 2001. Inflammation and cancer: back to Virchow? Lancet 357: 539- 45.
5. Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature 420: 860- 7.
6. Balducci L, Ershler WB. 2005. Cancer and ageing: a nexus at several levels. Nat Rev Cancer 5: 655- 62.
7. Rao VP, Poutahidis T, Ge Z, Nambiar PR, et al. 2006. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 66: 7395- 400.
8. Sansone P, Storci G, Tavolari S, Guarnieri T, et al. 2007. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 117: 3988- 4002.
9. Iliopoulos D, Hirsch HA, Wang G, Struhl K. 2011. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc Natl Acad Sci USA 108: 1397- 402.
10. Marotta LL, Almendro V, Marusyk A, Shipitsin M, et al. 2011. The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors. J Clin Invest 121: 2723- 35.
11. Studebaker AW, Storci G, Werbeck JL, Sansone P, et al. 2008. Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res 68: 9087- 95.
12. Storci G, Sansone P, Mari S, D'Uva G, et al. 2010. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype. J Cell Physiol 225: 682- 91.
13. Korkaya H, Liu S, Wicha MS. 2011. Regulation of cancer stem cells by cytokine networks: Attacking cancer's inflammatory roots. Clin Cancer Res 17: 6125- 9.
14. Rodier F, Campisi J. 2011. Four faces of cellular senescence. J Cell Biol 192: 547- 56.
15. Coppé JP, Desprez PY, Krtolica A, Campisi J. 2010. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5: 99- 118.
16. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, et al. 2008. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133: 1019- 31.
17. Knüpfer H, Preiss R. 2007. Significance of interleukin-6 (IL-6) in breast cancer. Breast Cancer Res Treat 102: 129- 35.
18. Shimono Y, Zabala M, Cho RW, Lobo N, et al. 2009. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138: 592- 603.
19. Molyneux G, Geyer FC, Magnay FA, McCarthy A, et al. 2010. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7: 403- 17.
20. Li L, Neaves WB. 2006. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66: 4553- 7. Erratum in: Cancer Res 2006. 66: 6458.
21. Medzhitov R. 2008. Origin and physiological roles of inflammation. Nature 454: 428- 35.
22. Ehninger A, Trumpp A. 2011. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 208: 421- 8.
23. Gyorki DE, Asselin-Labat ML, van Rooijen N, Lindeman GJ, et al. 2009. Resident macrophages influence stem cell activity in the mammary gland. Breast Cancer Res 11: R62.
24. Biagi E, Nylund L, Candela M, Ostan R, et al. 2010. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5: e10667.
25. Biagi E, Candela M, Franceschi C, Brigidi P. 2011. The aging gut microbiota: new perspectives. Ageing Res Rev 10: 428- 9.
26. Biagi E, Candela M, Fairweather-Tait S, Franceschi C, et al. 2011. Ageing of the human metaorganism: the microbial counterpart. Age (Dordr), in print, DOI: 10.1007/s11357-011-9217-5.
27. Calle EE, Thun MJ. 2004. Obesity and cancer. Oncogene 23: 6365- 78.
28. Gregor MF, Hotamisligil GS. 2011. Inflammatory mechanisms in obesity. Annu Rev Immunol 29: 415- 45.
29. Perry JM, Li L. 2007. Disrupting the stem cell niche: good seeds in bad soil. Cell 129: 1045- 7.
30. Orford KW, Scadden DT. 2008. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet 9: 115- 28.
31. Carlesso N, Cardoso AA. 2010. Stem cell regulatory niches and their role in normal and malignant hematopoiesis. Curr Opin Hematol 17: 281- 6.
32. Simons BD, Clevers H. 2011. Strategies for homeostatic stem cell self-renewal in adult tissues. Cell 145: 851- 62.
33. Watson CJ, Oliver CH, Khaled WT. 2011. Cytokine signalling in mammary gland development. J Reprod Immunol 88: 124- 9.
34. Fulop T, Larbi A, Witkowski JM, McElhaney J, et al. 2010. Aging, frailty and age-related diseases. Biogerontology 11: 547- 63.
35. Martin OA, Redon CE, Dickey JS, Nakamura AJ, et al. 2011. Para-inflammation mediates systemic DNA damage in response to tumor growth. Commun Integr Biol 4: 78- 81.
36. Biswas SK, Mantovani A. 2010. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11: 889- 96.
37. Ulrich CM, Bigler J, Potter JD. 2006. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 6: 130- 40.
38. Giovannini S, Onder G, Liperoti R, Russo A, et al. 2011. Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals. J Am Geriatr Soc 59: 1679- 85.
39. Franceschi C, Bonafè M, Valensin S. 2000. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 18: 1717- 20.
40. Lyons TR, O'Brien J, Borges VF, Conklin MW, et al. 2011. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 17: 1109- 15.
41. Hei TK, Zhou H, Chai Y, Ponnaiya B, et al. 2011. Radiation induced non-targeted response: mechanism and potential clinical implications. Curr Mol Pharmacol 4: 96- 105.
42. Burr KL, Robinson JI, Rastogi S, Boylan MT, et al. 2010. Radiation-induced delayed bystander-type effects mediated by hemopoietic cells. Radiat Res 173: 760- 8.
43. Dieriks B, De Vos WH, Derradji H, Baatout S, et al. 2010. Medium-mediated DNA repair response after ionizing radiation is correlated with the increase of specific cytokines in human fibroblasts. Mutat Res 687: 40- 8.
44. Ivanov VN, Zhou H, Ghandhi SA, Karasic TB, et al. 2010. Radiation-induced bystander signaling pathways in human fibroblasts: a role for interleukin-33 in the signal transmission. Cell Signal 22: 1076- 87.
45. Connelly L, Robinson-Benion C, Chont M, Saint-Jean L, et al. 2007. A transgenic model reveals important roles for the NF-kappa B alternative pathway (p100/p52) in mammary development and links to tumorigenesis. J Biol Chem 282: 10028- 35.
46. Pratt MA, Tibbo E, Robertson SJ, Jansson D, et al. 2009. The canonical NF-kappaB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population. Oncogene 28: 2710- 22.
47. Scheel C, Eaton EN, Li SH, Chaffer CL, et al. 2011. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145: 926- 40.
48. Sullivan NJ, Sasser AK, Axel AE, Vesuna F, et al. 2009. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28: 2940- 7.
49. Vorbach C, Capecchi MR, Penninger JM. 2006. Evolution of the mammary gland from the innate immune system? BioEssays 28: 606- 16.
50. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, et al. 2003. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983- 8.
51. Liu M, Sakamaki T, Casimiro MC, Willmarth NE, et al. 2010. The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Res 70: 10464- 73.
52. Guzman ML, Rossi RM, Karnischky L, Li X, et al. 2005. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105: 4163.
53. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100: 57- 70.
54. Ancrile B, Lim KH, Counter CM. 2007. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev 21: 1714- 9.
55. Iliopoulos D, Hirsch HA, Struhl K. 2009. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139: 693- 706.
56. D'Anello L, Sansone P, Storci G, Mitrugno V, et al. 2010. Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells. Mol Cancer 9: 300.
57. Gao SP, Mark KG, Leslie K, Pao W, et al. 2007. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest 117: 3846- 56.
58. Hartman ZC, Yang XY, Glass O, Lei G, et al. 2011. HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis. Cancer Res 71: 4380- 91.
59. Li N, Grivennikov SI, Karin M. 2011. The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 19: 429- 31.
60. Borrello MG, Degl'Innocenti D, Pierotti MA. 2008. Inflammation and cancer: the oncogene-driven connection. Cancer Lett 267: 262- 70.
61. Hernandez-Vargas H, Ouzounova M, Le Calvez-Kelm F, Lambert MP, et al. 2011. Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells. Epigenetics 6: 428- 39.
62. Hodge DR, Peng B, Cherry JC, Hurt EM, et al. 2005. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res 65: 4673- 82.
63. Kalluri R, Zeisberg M. 2006. Fibroblasts in cancer. Nat Rev Cancer 6: 392- 401.
64. Bhowmick NA, Neilson EG, Moses HL. 2004. Stromal fibroblasts in cancer initiation and progression. Nature 432: 332- 7.
65. Allen M, Louise Jones J. 2011. Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 223: 162- 76.
66. Cristofalo VJ. 2005. SA beta Gal staining: biomarker or delusion. Exp Gerontol 40: 836- 8.
67. Yang G, Rosen DG, Zhang Z, Bast RC Jr, et al. 2006. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci USA 103: 16472- 7.
68. Campbell I, Qiu W, Haviv I. 2011. Genetic changes in tumour microenvironments. J Pathol 223: 450- 8.
69. Eng C, Leone G, Orloff MS, Ostrowski MC. 2009. Genomic alterations in tumor stroma. Cancer Res 69: 6759- 64.
70. Houghton J, Li H, Fan X, Liu Y, et al. 2010. Mutations in bone marrow-derived stromal stem cells unmask latent malignancy. Stem Cells Dev 19: 1153- 66.
71. Kiaris H, Chatzistamou I, Trimis G, Frangou-Plemmenou M, et al. 2005. Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Res 65: 1627- 30.
72. Addadi Y, Moskovits N, Granot D, Lozano G, et al. 2010. p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner. Cancer Res 70: 9650- 8.
73. Herbert BS, Chanoux RA, Liu Y, Baenziger PH, et al. 2010. A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers. Oncotarget 1: 405- 22.
74. Littlepage LE, Egeblad M, Werb Z. 2005. Coevolution of cancer and stromal cellular responses. Cancer Cell 7: 499- 500.
75. Moody CA, Laimins LA. 2009. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog 5: e1000605.
76. Kan CY, Iacopetta BJ, Lawson JS, Whitaker NJ. 2005. Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer 93: 946- 8.
77. Qian B, Deng Y, Im JH, Muschel RJ, et al. 2009. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One 4: e6562.
78. Chen J, Yao Y, Gong C, Yu F, et al. 2011. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell 19: 541- 5.
79. Campbell MJ, Tonlaar NY, Garwood ER, Huo D, et al. 2011. Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Res Treat 128: 703- 11.
80. Walter M, Liang S, Ghosh S, Hornsby PJ, et al. 2009. Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene 28: 2745- 55.
81. Bussard KM, Smith GH. 2011. The mammary gland microenvironment directs progenitor cell fate in vivo. Int J Cell Biol 2011: 451676.
82. Dirat B, Bochet L, Dabek M, Daviaud D, et al. 2011. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 71: 2455- 65.
83. Lepperdinger G. 2011. Inflammation and mesenchymal stem cell aging. Curr Opin Immunol 23: 518- 24.
84. Pull SL, Doherty JM, Mills JC, Gordon JI, et al. 2005. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci USA 102: 99- 104.
85. Ergen AV, Goodell MA. 2010. Mechanisms of hematopoietic stem cell aging. Exp Gerontol 45: 286- 90.
86. Woolthuis CM, de Haan G, Huls G. 2011. Aging of hematopoietic stem cells: Intrinsic changes or micro-environmental effects? Curr Opin Immunol 23: 512- 7.
87. Rübe CE, Fricke A, Widmann TA, Fürst T, et al. 2011. Accumulation of DNA damage in hematopoietic stem and progenitor cells during human aging. PLoS One 6: e17487.
88. Chambers SM, Shaw CA, Gatza C, Fisk CJ, et al. 2007. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 5: e201.
89. Bagnara GP, Bonsi L, Strippoli P, Bonifazi F, et al. 2000. Hemopoiesis in healthy old people and centenarians: well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine network. J Gerontol A Biol Sci Med Sci 55: B61- 6; discussion B67- 70.
90. Marcondes AM, Ramakrishnan A, Deeg HJ. 2009. Myeloid malignancies and the marrow microenvironment: some recent studies in patients with MDS. Curr Cancer Ther Rev 5: 310- 4.
91. Raaijmakers MH, Mukherjee S, Guo S, Zhang S, et al. 2010. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464: 852- 7.
92. Elsawa SF, Almada LL, Ziesmer SC, Novak AJ, et al. 2011. GLI2 transcription factor mediates cytokine cross-talk in the tumor microenvironment. J Biol Chem 286: 21524- 34.
93. Gilbert LA, Hemann MT. 2010. DNA damage-mediated induction of a chemoresistant niche. Cell 143: 355- 66.
94. Goodman JE, Hofseth LJ, Hussain SP, Harris CC. 2004. Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ Mol Mutagen 44: 3- 9.
95. Bowen KA, Doan HQ, Zhou BP, Wang Q, et al. 2009. PTEN loss induces epithelial-mesenchymal transition in human colon cancer cells. Anticancer Res 29: 4439- 49.
96. Henry CJ, Marusyk A, DeGregori J. 2011. Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection? Aging (Albany NY) 3: 643- 56.
97. Cao L, Li W, Kim S, Brodie SG, et al. 2003. Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. Genes Dev 17: 201- 13.
98. Sahin E, Depinho RA. 2010. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 464: 520- 8.
99. Jones SA, Scheller J, Rose-John S. 2011. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest 121: 3375- 83.